高级检索
当前位置: 首页 > 详情页

Anxiety disorders are associated with increased plasma adrenomedullin level and left ventricular hypertrophy in patients with hypertension

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Taishan Med Univ, Liaocheng Peoples Hosp, Dept Cardiol, Tai An 252000, Shandong, Peoples R China [2]Capital Med Univ, Beijing Friendship Hosp, Dept Cardiol, Beijing, Peoples R China [3]Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia
出处:
ISSN:

关键词: Anxiety disorder essential hypertension left ventricular hypertrophy adrenomedullin

摘要:
Objective: To investigate the association between anxiety disorders and left ventricular hypertrophy in patients with essential hypertension. Methods: Left ventricular structure and function were assessed with echocardiography in 56 patients with essential hypertension and anxiety disorder (study group) and in 56 patients with hypertension only (control group). Serum adrenomedullin levels were also measured in these patients. Results: There was no statistically significant difference in the left ventricular ejection fraction between the study and the control group (54.21 +/- 88.81% versus 56.01 +/- 7.85%, p > 0.05). The left ventricular mass index (LVMI) in study group was higher than in control group (137.05 +/- 9.42 versus 123.57 +/- 7.01 g/m(2), p = 0.001). The plasma levels of adrenomedullin in study group was higher than in control group (25.97 +/- 5.48 versus 18.32 +/- 6.97 ng/L, p = 0.001). Levels of plasma adrenomedullin were positively correlated with LVMI in the study (r = 0.734, p < 0.05) and control group (r = 0.592, p < 0.05). Conclusion: Anxiety disorders are associated with elevated plasma adrenomedullin levels and increased left ventricular hypertrophy in patients with essential hypertension. The clinical significance of these changes requires further investigation.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
JCR分区:
出版当年[2012]版:
Q3 PHARMACOLOGY & PHARMACY Q3 PERIPHERAL VASCULAR DISEASE
最新[2024]版:
Q2 PERIPHERAL VASCULAR DISEASE Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均[2021-2025] 出版当年[2012版] 出版当年五年平均[2008-2012] 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Taishan Med Univ, Liaocheng Peoples Hosp, Dept Cardiol, Tai An 252000, Shandong, Peoples R China
通讯作者:
通讯机构: [1]Taishan Med Univ, Liaocheng Peoples Hosp, Dept Cardiol, Tai An 252000, Shandong, Peoples R China [3]Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:819 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)